DK1175227T3 - Monoklonalt antistof som er rettet mod celler fra humant nyrekarcinom - Google Patents
Monoklonalt antistof som er rettet mod celler fra humant nyrekarcinomInfo
- Publication number
- DK1175227T3 DK1175227T3 DK00925425T DK00925425T DK1175227T3 DK 1175227 T3 DK1175227 T3 DK 1175227T3 DK 00925425 T DK00925425 T DK 00925425T DK 00925425 T DK00925425 T DK 00925425T DK 1175227 T3 DK1175227 T3 DK 1175227T3
- Authority
- DK
- Denmark
- Prior art keywords
- monoclonal antibody
- human renal
- carcinoma cells
- renal carcinoma
- antibody targeting
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
- A61K51/106—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from kidney or bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3038—Kidney, bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Optics & Photonics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9905942A FR2793497B1 (fr) | 1999-05-10 | 1999-05-10 | Anticorps monoclonal dirige contre les cellules de carcinome renal humain |
PCT/FR2000/001258 WO2000067792A1 (fr) | 1999-05-10 | 2000-05-10 | Anticorps monoclonal dirige contre les cellules de carcinome renal humain |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1175227T3 true DK1175227T3 (da) | 2007-08-27 |
Family
ID=9545417
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00925425T DK1175227T3 (da) | 1999-05-10 | 2000-05-10 | Monoklonalt antistof som er rettet mod celler fra humant nyrekarcinom |
Country Status (14)
Country | Link |
---|---|
US (1) | US7074613B1 (de) |
EP (1) | EP1175227B1 (de) |
JP (1) | JP2002543811A (de) |
AT (1) | ATE359091T1 (de) |
AU (1) | AU781426B2 (de) |
CA (1) | CA2373631A1 (de) |
CY (1) | CY1107060T1 (de) |
DE (1) | DE60034330T2 (de) |
DK (1) | DK1175227T3 (de) |
ES (1) | ES2284493T3 (de) |
FR (1) | FR2793497B1 (de) |
IL (2) | IL146396A0 (de) |
PT (1) | PT1175227E (de) |
WO (1) | WO2000067792A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2793497B1 (fr) | 1999-05-10 | 2003-04-18 | Centre Nat Rech Scient | Anticorps monoclonal dirige contre les cellules de carcinome renal humain |
ES2266448T3 (es) * | 2001-02-07 | 2007-03-01 | Wilex Ag | Linea de celulas de hibridona g250 y su uso para producir anticuerpos monoclonales. |
US20040077081A1 (en) | 2001-02-07 | 2004-04-22 | Egbert Oosterwijk | Hybridoma cell line g250 and its use for producing monoclonal antibodies |
KR100623128B1 (ko) * | 2002-01-02 | 2006-09-14 | 제넨테크, 인크. | 종양의 진단 및 치료 방법 및 이를 위한 조성물 |
US20050074901A1 (en) * | 2002-02-13 | 2005-04-07 | John Castracane | Methods and assays for detecting and quantifying the human p53 inducible gene protein |
AU2003280442B2 (en) | 2002-07-01 | 2009-02-05 | Wilex Ag | Co-administration of CG250 and IL-2 or IFN-alpha for treating cancer such as renal cell carcinomas |
CN111732660B (zh) * | 2020-07-31 | 2020-12-29 | 河北佑仁生物科技有限公司 | 骨髓间充质干细胞和单克隆抗体联合治疗癌症 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4713352A (en) * | 1981-08-31 | 1987-12-15 | Sloan-Kettering Institute For Cancer Reseach | Monoclonal antibody panel for early diagnosis and therapy of renal carcinoma |
US4650756A (en) * | 1981-08-31 | 1987-03-17 | Sloan Kettering Institute For Cancer Research | Monoclonal antibodies to cell surface antigens of human renal cancer |
DE3485712D1 (de) * | 1983-03-11 | 1992-06-17 | Sloan Kettering Inst Cancer | Monoklonale antikoerper gegen menschliche nierenkrebsantigene und verfahren. |
WO1988008854A1 (en) * | 1987-05-06 | 1988-11-17 | Egbert Oosterwijk | Monoclonal antibodies to renal cell carcinoma |
US5145773A (en) | 1989-05-25 | 1992-09-08 | Sloan-Kettering Institute For Cancer Research | Method to detect sensitivity to alpha-interferon therapy |
US5270202A (en) * | 1989-11-03 | 1993-12-14 | Syamal Raychaudhuri | Anti-idiotypic antibodies to human melanoma-associated proteoglycan antigen |
US6235280B1 (en) * | 1996-04-12 | 2001-05-22 | Malaya Chatterjee | Methods of delaying development of CEA-associated tumors using anti-idiotype antibody 3H1 |
FR2793497B1 (fr) | 1999-05-10 | 2003-04-18 | Centre Nat Rech Scient | Anticorps monoclonal dirige contre les cellules de carcinome renal humain |
US6632431B2 (en) * | 2000-05-16 | 2003-10-14 | New York University | Anti-idiotypic antibody against FimH adhesion of uropathogenic type I-fimbriated Escherichia coli, compositions containing same and method for using same |
-
1999
- 1999-05-10 FR FR9905942A patent/FR2793497B1/fr not_active Expired - Fee Related
-
2000
- 2000-05-10 WO PCT/FR2000/001258 patent/WO2000067792A1/fr active IP Right Grant
- 2000-05-10 ES ES00925425T patent/ES2284493T3/es not_active Expired - Lifetime
- 2000-05-10 CA CA002373631A patent/CA2373631A1/fr not_active Abandoned
- 2000-05-10 DK DK00925425T patent/DK1175227T3/da active
- 2000-05-10 IL IL14639600A patent/IL146396A0/xx active IP Right Grant
- 2000-05-10 PT PT00925425T patent/PT1175227E/pt unknown
- 2000-05-10 AU AU44151/00A patent/AU781426B2/en not_active Ceased
- 2000-05-10 JP JP2000616817A patent/JP2002543811A/ja active Pending
- 2000-05-10 EP EP00925425A patent/EP1175227B1/de not_active Expired - Lifetime
- 2000-05-10 US US09/959,911 patent/US7074613B1/en not_active Expired - Fee Related
- 2000-05-10 AT AT00925425T patent/ATE359091T1/de active
- 2000-05-10 DE DE60034330T patent/DE60034330T2/de not_active Expired - Lifetime
-
2001
- 2001-11-08 IL IL146396A patent/IL146396A/en not_active IP Right Cessation
-
2007
- 2007-07-02 CY CY20071100865T patent/CY1107060T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
IL146396A (en) | 2007-06-17 |
US7074613B1 (en) | 2006-07-11 |
ES2284493T3 (es) | 2007-11-16 |
PT1175227E (pt) | 2007-07-18 |
IL146396A0 (en) | 2002-07-25 |
EP1175227A1 (de) | 2002-01-30 |
AU4415100A (en) | 2000-11-21 |
CA2373631A1 (fr) | 2000-11-16 |
AU781426B2 (en) | 2005-05-26 |
DE60034330T2 (de) | 2007-12-20 |
EP1175227B1 (de) | 2007-04-11 |
DE60034330D1 (de) | 2007-05-24 |
CY1107060T1 (el) | 2012-10-24 |
FR2793497A1 (fr) | 2000-11-17 |
JP2002543811A (ja) | 2002-12-24 |
WO2000067792A9 (fr) | 2002-09-12 |
ATE359091T1 (de) | 2007-05-15 |
WO2000067792A1 (fr) | 2000-11-16 |
FR2793497B1 (fr) | 2003-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1107060T1 (el) | Μονοκλωνικο αντισωμα κατευθυνομενο κατα των κυτταρων του ανθρωπινου νεφρικου καρκινωματος | |
IS8950A (is) | Einklóna mótefni gegn CTLA-4 úr manni. | |
NZ337413A (en) | Antibodies that bind to Prostate Stem Cell Antigen (PSCA) to treat prostate cancer. | |
TR199900639T2 (xx) | Olanzapin dihidrat D. | |
ZA945364B (en) | Antibodies specific for human prostate glandular kallikrein | |
DK1950302T3 (da) | Streptokok-antigener. | |
EA200300464A1 (ru) | ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ | |
SE9901462D0 (sv) | Novel compound | |
DOP2001000219A (es) | Applicator | |
BR0015872A (pt) | Agentes antitrombóticos | |
ES2174150T3 (es) | Procedimiento para la obtencion de 4-hidroxianilinas. | |
TR199701482T1 (xx) | Osteoporozu �nlemek i�in alendronat kullan�lmas�. | |
NO974852D0 (no) | Humant <beta>-2-integrin-<alfa>-subenhet | |
NO20005833D0 (no) | Humaniserte antistoffer som gjenkjenner verotoksin II og cellelinje som produserer det samme | |
WO1992004464A3 (en) | Monoclonal antibodies against tenascin | |
DE60317462D1 (de) | Neuer monoklonaler antikörper und antigene gegen nematodenlarven | |
NO894555D0 (no) | Monoklonalt antistoff som spesifikt gjenkjenner n-glycolyl type gm2, hybridom som produserer antistoff og fremgangsmaate for fremstilling av hybridomet. | |
BR1100555B1 (pt) | anticorpos monoclonais humanizados. | |
WO2002040658A3 (en) | Isomerases | |
IT1301728B1 (it) | Preparazione di un complesso antianemico. | |
IT239134Y1 (it) | Dispositivo aspirante, particolarmente per w.c. | |
IT239289Y1 (it) | Lumino per sepolcri, immagini votive e simili. | |
ITFO980038U1 (it) | Europallet monoblocco. | |
ES1034918Y (es) | Tapa-asiento para bides. | |
ES1030353Y (es) | Mano para mortero, mejorada. |